Objective: Although Iodine-125 ( 125 I) has been widely used for in vitro studies because of its relatively long half-life (60.1 days), 125 I imaging is limited because of its low energy (27 -35 keV), even in an animal-dedicated system. In this study, imaging characteristics of 125 I were assessed using a small animal-dedicated imaging system and clinical scanner. 
Introduction
Iodine-125 ( 125 I) has been widely used for in vitro research because of its relatively long half-life (60.1 days). Various 125 I-labeled nucleic acids, antibodies, and ligands are commercially available or easily made in the laboratory using commercially available reagents and kits [1] [2] . Recently, in vivo 125 I imaging methods were developed, and both in vivo and in vitro experiments were performed using the same 125 I-labeled tracers [3] - [7] . However, in vivo imaging in animals using 125 I is limited because of its low energy (27 -35 keV) compared to Technetium-99m ( 99m Tc) or Iodine-123 ( 123 I) [8] . Although the clinical scanner was designed for imaging human patients, the clinical scanner has been used for animal imaging. Small animal imaging using a clinical scanner with a pinhole collimator and 99m Tc or 123 I has been reported [6] [9]- [12] . Although a small animal-dedicated scanner provides high resolution (submillimeter range), the clinical scanner is ready to use in clinics. Another advantage of the clinical scanner is the large field of view.
In this study, we investigated the feasibility for 125 I imaging using a clinical scanner without a pinhole collimator and compared its performance characteristics to a small animal scanner.
Materials and Methods

System Description
The Symbia TruePoint (Siemens Medical Solutions USA, Inc., Knoxville, TN, USA) clinical single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging system designed for human patients was used to assess 125 I characteristics. Low energy high-resolution (LEHR) and low energy all-purpose (LEAP) collimators were used. Each collimator consisted of 148 holes with a 1.11-mm diameter and 90 holes with a 1.45-mm diameter across the flats. Each of the two detector heads of the Symbia TruePoint SPECT system consisted of a 15.8-mm crystal thickness and a SPECT field of view of 40 cm (axial) by 50 cm (diameter).
The Siemens Inveon small animal positron emission tomography (PET)/SPECT/CT imaging system (Siemens Medical Solutions USA, Inc.) was used to assess the performance of 125 I. Mouse high resolution (MHR), mouse general purpose (MGP), and mouse high sensitivity (MHS) collimators with pinhole diameters of 0.5 mm, 1.0 mm, and 2.0 mm across the flats, respectively, were used. The Inveon SPECT/CT system consisted of two detector heads, an active area of 15 cm × 15 cm, [NaI(Tl)] scintillator crystal material, and 4624 crystal elements.
Spatial Resolution and Sensitivity
For the measurement of spatial resolution and sensitivity, a 1-mm point source was made using capillary tubes. The activities of 125 I and 99m Tc were 2.2 MBq and 3.3 MBq, respectively. The data acquisition time was 600 s. To determine the spatial resolution, profiles through peaks in count distributions were drawn in two orthogonal directions in middle slices. For each profile, full width at half maximum (FWHM) was measured by linearly interpolating the adjacent pixels at half or tenth of their maxima in the profile.
Image Quality
For the assessment of image quality, the National Electrical Manufacturers Association (NEMA) NU 4 Image Quality (IQ) Phantom was used [13] - [15] . The NU 4 IQ phantom is a cylindrical chamber that consists of three parts: five fillable rods with diameters of 1, 2, 3, 4, and 5 mm arranged in the top part; a uniform region in the middle part; and two cold components with a 10-mm diameter attached to the bottom part. The top and bottom regions are filled with nonradioactive water and air, respectively. The nonuniformity, recovery coefficient, and spillover ratio (SOR) were assessed using the NU 4 IQ phantom [14] . 
Data Acquisition
The step-and-shoot mode was used for data acquisition. The acquisition time for each view was 100 s, total imaging time was 3200 s, rotation degree was 180˚, degree of configuration was 180˚, and magnification factor was 3.2.
Reconstruction
The ordered subset expectation maximization three-dimensional (OSEM-3D) algorithm was used in the small animal scanner, and the Flash 3D algorithm was used in the clinical scanner. The number of iterations was 8, and the number of sets was 4. The windows for 125 I and 99m
Tc were 35 ± 11 keV and 140 ± 14 keV, respectively.
Animal Studies
Animal study was carried out in accordance with guideline provided by the Institutional Animal Care and Use Committee (IACUC) and Institutional review board (IRB) in Korea Institute of Radiological and Medical Sciences. In addition, all experimental protocols were approved by IACUC and IRB in Korea Institute of Radiological and Medical Sciences. 125 I was injected into BALB/c mice (weight: 20 g, female, SLC JAPAN) and the mice were scanned for 1 hour after injection. Planar mode imaging and SPECT mode imaging were performed. The 1.0-MGP collimator was used in the small animal scanner, and the LEAP collimator was used in the clinical scanner. The activity concentrations for the animal scanner and clinical scanner were 18.9 MBq and 14.4 MBq, respectively.
In vivo radiolabeled antibody imaging was assessed using a human breast cancer mouse model. KPL-4 and MDA-MB-231 xenografts were established in female nude mice ( 125 I-labeled HER2-targeting antibody was injected, and its activity concentration was 8.81 MBq. Tc point sources. The results were similar to a previous study and specification sheets provided by the manufacturer [15] - [17] . At source-to-collimator distances of 25, 30, and 35 mm, the sensitivities for the Symbia TruePoint were 30.83, 30.55, and 30.35 cps/MBq, respectively, using the LEHR collimator and 68.89, 68.13, and 67.68 cps/MBq, respectively, using the LEAP collimator. Tc point sources. These results were similar to a previous study [15] - [17] . Tc measured by the NU 4 IQ phantom was similar to 125 I (Figure 3(b) ). Figure 4 shows the recovery coefficient of each hot rod in a cold background as a function of rod diameter. However, there are two problems, image noise and resolution of the clinical scanner, for evaluating recovery coefficients. Generally, the theoretical maximum value of RC rod is 1.0, but it can be more than 1.0 because of image noise. The resolution of the clinical scanner was 8.89 mm FWHM in the LEHR collimator and 9.25 mm FWHM in the LEAP collimator for 125 I point sources. Therefore, detecting hot rods (1.0 -5.0 mm) was impossible. For these reasons, calculation of this parameter on the clinical scanner was incomplete and was predicted by the position of the hot rod in the object based on the physical dimensions of the phantom. 
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Discussion
This comparative result of 125 I showed that the sensitivity was comparable between the Inveon scanner and Symbia TruePoint scanner. An important limitation of the evaluation of the clinical scanner stemmed mostly from the source-to-collimator distance and small phantom object size. The recovery coefficient was indefinite, and the spillover ratio was overestimated in the clinical scanner. Nevertheless, the uniformity of the clinical scanner was acceptable because of the parallel collimator.
For the reasons mentioned above, attempting small animal imaging by a clinical scanner is more important than statistically analysis. Not surprisingly, the performance of the small animal scanner was undoubtedly better than that of the clinical scanner. Even small components could be distinguished with less blurring than clinical scanner. However, Figure 6 (e) implies an unexpected possibility for small animal imaging beyond numeric data. Accumulation of 125 I-labeled target agents in the hind legs of a xenograft mouse model of human cancer was confirmed sufficiently for the purpose in spite of planar mode imaging. These results are acquired by the daily routine methods for patient imaging in hospitals without special modifications, such as attaching pinhole collimators.
The small animal imaging system is an important tool with great potential for development of pharmaceutical agents aimed at diagnosis and therapy. Therefore, the research demand for small animal imaging has also increased over the last decade [4] - [7] . The resolution of small animal scanners is generally in the submillimeter range. This range is a considerable improvement compared to the 8 mm or higher range resolution of existing clinical scanners [18] [19] . Because a high-resolution imaging system is not always available in clinical environment, clinical scanner for small animal imaging would be feasible imaging modality for animal imaging and research.
Conclusion
This study collectively showed that 125 I animal imaging using the Symbia TruePoint scanner was feasible for animal imaging. The advantages of using the clinical scanner include its large field of view, which would allow imaging of 2 -3 mice, and availability, since it could be used where a dedicated small animal scanner system is not available. Small animal imaging using a clinical scanner is more accessible and readily available. This study shows that using clinical scanner can expand small animal imaging research opportunities. Our results also showed the possibility of 125 I for clinical use although 125 I imaging was not feasible due to low energy of 125 I for clinical imaging.
